In a placebo-controlled clinical trial, 2 g/day of N. sativa seed could decrease the plasma level of inflammatory cytokines such as TNF-α, C-reactive protein, and nuclear factor kappa-B (NF-κB) in patients with NAFLD (Darand et al., 2019b). The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.